leadf
logo-loader
Silo Pharma Inc - Three companies pushing the field of psychedelic medicine forward to present at Proactive virtual conference on February 23

Hear executives from Silo Pharma and Lobe Sciences at Proactive's psychedelic-themed virtual...

1 week, 4 days ago
Insight

Aion Therapeutic: Meet the team using artificial intelligence to create a...

Hear from executives at Aion Therapeutic, Lobe Sciences and Silo Pharma at Proactive's...

1 week, 4 days ago
Deep dive

Numinus Wellness looking to position itself at the forefront of psychedelics...

Through its Bioscience lab, Numinus is the first public company in Canada to receive a licence...

2 weeks ago
Deep dive

MindMed seeks to harvest the power of psychedelics to treat mental health...

The New York City-based company has several projects in various stages from planning to ongoing...

3 weeks ago
Deep dive

PharmaDrug looking to develop and commercialise a range of psychedelics,...

The company owns 80% of Pharmadrug GmbH, a German medical cannabis distributor, with a Schedule...

3 weeks, 2 days ago

Numinus research takes big step forward after receiving new amendments to...

Numinus Wellness (CVE: NUMI) CEO Payton Nyquvest joined Steve Darling from Proactive to share news the company has received amendments to their licensing that will now allow the company to enhance their ability to lead psychedelics research and support the global psychedelics sector. Nyquvest...

1 day, 5 hours ago